Work

Abstract PS2-11-28: Gdc-4198, a next-generation CDK4/2 inhibitor, induces durable cell cycle arrest and overcomes CDK2-driven adaptation to CDK4 inhibition

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-11-28

Authors: M. Hafner, S. Vartanian, G. Luca, N. Kosaisawe, M. Hwang, E. Lin, L. Wang, J. Oeh, J. Vijay, K. N. Islam, A. Zheng, K. Samy, U. Segal, J. Moffat, D. Zingg, A. Collier, I. Sanidas, J. Xie, S. A. Wander

Institutions: Genentech, Roche (Canada), Massachusetts General Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129449541

Cites:

Cited by: 1

Related to: